Search Results for citation:"86 FR 8381"

The Drug Enforcement Administration (DEA) has announced that Sterling Pharma USA LLC has submitted an application to become a bulk manufacturer of controlled substances. Specifically, they plan to produce Tetrahydrocannabinols from hemp extract. People who are currently registered as bulk manufacturers of these substances, or who are applying to be, have the opportunity to file comments or objections regarding this application by April 6, 2021. They can also request a hearing before the same deadline.

Noramco Inc has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances, including synthetic versions of Marihuana Extract, Marihuana, and Tetrahydrocannabinols. The company intends to produce these substances as active pharmaceutical ingredients and reference standards for their customers. Interested parties are invited to submit comments, objections, or a request for a hearing regarding this application by April 6, 2021. Written comments should be sent to the DEA's Federal Register Representative in Springfield, Virginia.

The Department of Justice (DOJ), specifically the Executive Office for Immigration Review (EOIR), is seeking public feedback on a new information collection process. This initiative involves using the FOIAXpress Public Access Link to electronically communicate and deliver records to the public. They estimate approximately 33,984 responses yearly, with each response taking about three minutes, resulting in 1,699 total annual burden hours. Public comments are welcome until March 8, 2021, regarding the necessity and efficiency of this collection method.